Peripheral Stent Implants Market By Based on Product Type (Bare Metal Stents, Covered Stents, Drug-Eluting Stents), By Application (Hospitals, Ambulatory Surgical Centers) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: May 2023
- Report ID: 77429
- Number of Pages: 289
Peripheral Stent Implants Market Overview
Peripheral Artery Disease (PAD) is a common cardiovascular issue in which constricted arteries limit blood flow to the lower limbs (legs). When an individual has PAD, blood flow to the extremities — mainly the legs — is insufficient to meet the body’s needs. This results in symptoms, the most common of which is leg pain during walking (intermittent claudication).
Peripheral stents are small tubular metal scaffolds that can be put into peripheral vessels to relieve constriction or blockage in arteries or veins, improving blood flow. Stents are typically made of nitinol and can be plain, drug-coated, or covered in a prosthetic material. A balloon (angioplasty) is usually used first to flatten the obstruction against the vessel walls, allowing the stent to open up more easily.
Stents for the peripheral arteries are frequently used in conjunction with balloon angioplasty. Peripheral stent implants keep a blocked or clogged artery open so that blood can flow through it. The stent, which is a small lattice-shaped wire mesh tube, props open the artery and stays in place indefinitely. The stent is inserted into the peripheral artery through the catheter. Restenosis, or the narrowing of a blood vessel again, can be prevented with recent technological advancements. Drug-Eluting Stents (DES) and balloons, which are coated with medication to ensure excellent circulation in the treated channel, are now accessible. Peripheral vascular disease is a long-term disorder that is often linked to other illnesses such as coronary artery disease or diabetes.
Based on Product Type:
- Bare Metal Stents
- Covered Stents
- Drug-Eluting Stents
Based on End-Use:
- Ambulatory Surgical Centers
Based on Region:
- North America
- South America
- Middle East & Africa
Drivers for the Global Peripheral Stent Implants Market:
The demand for peripheral stent implantation is expected to increase as the frequency of peripheral vascular disease surges around the globe. Furthermore, as vascular stenting operations become more common, the demand for peripheral stents is increasing, thereby propelling the economic growth of the global peripheral stent implants market forward.
Restraints the Global Peripheral Stent Implants Market:
With developments in technology, the cost of stents increases as well. Drug-eluting stents, for example, are more expensive than bare-metal stents. This high cost is a huge impediment in developing nations, where a majority of the population lacks health insurance. Technologically advanced stents are too costly for patients in developing countries. Furthermore, owing to a lack of labor and supply chain interruptions, the COVID-19 pandemic is also likely to have a negative impact on the global peripheral stent implants market.
Opportunities for the Global Peripheral Stent Implants Market:
Manufacturers in the peripheral stent implants market are now concentrating their efforts on launching new products to gain a stronger position in this industry. Furthermore, intense competition among global peripheral stent implants market participants is due to the development and marketing of new, technologically sophisticated products based on patient needs. Advanced peripheral stents are currently being introduced by manufacturers to help clinicians simplify their interventional procedures.
Trends for the Global Peripheral Stent Implants Market:
Key manufacturers are likely to increase their investments in providing customized and novel peripheral vascular stents, as well as place a greater emphasis on low-cost peripheral artery stent development.
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Cook Medical
- Cardinal Health
- iVascular S.L.U.
- Medtronic Plc.
- Terumo Europe NV
- W. L. Gore & Associates Inc.
Recent Developments of Major Players
In July, 2019, CCRM Terumo Corporation released its MISAGO Rx, a self-expanding peripheral stent for iliac artery treatments in Japan.
For the Peripheral Stent Implants Market research study, the following years have been considered to estimate the market size:
Attribute Report Details
Short Term Projection Year
Long Term Projection Year
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
North America, Europe, Asia-Pacific, South America, Middle East & Africa
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
| Single User|
USD / per unit
| Multi User|
USD / per unit
| Corporate User|
USD / per unit
|Report Library Access|
|Data Set (Excel)|
|Company Profile Library Access|
|Free Custumization||No||up to 10 hrs work||up to 30 hrs work|
|Accessibility||1 User||2-5 User||Unlimited|
|Analyst Support||up to 20 hrs||up to 40 hrs||up to 50 hrs|
|Benefit||Up to 20% off on next purchase||Up to 25% off on next purchase||Up to 30% off on next purchase|
|Buy Now ($ 3,499)||Buy Now ($ 4,299)||Buy Now ($ 4,999)|